Conditions: Allergic Conjunctivitis
Keywords: Allergies Ocular
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 383
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate olopatadine 0.2% QD (once per day) compared to olopatadine 0.1% BID (twice per day) in the treatment of ocular itching associated with allergic conjunctivitis.

Detailed description:

Arms:
arm 1: Olopatadine hydrochloride ophthalmic solution 0.2% in the morning and olopatadine 0.2% vehicle in the evening, 1 drop in each eye for 14 days arm 2: Olopatadine hydrochloride ophthalmic solution 0.1%, 1 drop in each eye in the morning and evening, for 14 days

Interventions: intervention 1: Olopatadine Hydrochloride Ophthalmic Solution 0.2% intervention 2: Olopatadine Hydrochloride Ophthalmic Solution 0.1% intervention 3: Olopatadine 0.2% Vehicle
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: Inactive ingredients used as placebo comparator

Protocol document: